ADENTRA (TSE:ADEN) Given a C$60.00 Price Target at Raymond James

ADENTRA (TSE:ADENGet Free Report) has been assigned a C$60.00 price target by stock analysts at Raymond James in a research report issued to clients and investors on Friday,BayStreet.CA reports. The firm currently has a “strong-buy” rating on the stock.

A number of other research analysts have also commented on the company. National Bankshares increased their price objective on ADENTRA from C$57.00 to C$60.00 and gave the company an “outperform” rating in a research report on Monday, October 7th. Acumen Capital dropped their price objective on ADENTRA from C$56.00 to C$54.00 in a report on Friday, November 15th. Finally, Stifel Nicolaus reduced their target price on shares of ADENTRA from C$53.00 to C$50.00 and set a “buy” rating on the stock in a research note on Thursday, October 17th. Five research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, ADENTRA has an average rating of “Buy” and a consensus target price of $55.14.

Get Our Latest Research Report on ADENTRA

ADENTRA Trading Up 2.7 %

TSE:ADEN opened at $36.64 on Friday. The stock has a market capitalization of $916.73 million, a P/E ratio of 13.77 and a beta of 1.57. The firm has a 50 day moving average of $39.51 and a 200-day moving average of $39.28. ADENTRA has a 1 year low of $29.81 and a 1 year high of $45.25.

About ADENTRA

(Get Free Report)

ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.

Featured Stories

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.